Eric Kwasi Elliason,
Atul Khajuria,
Stephen Monday,
J. Samuel Kamanda,
- Teaching Assistant, Faculty of Allied Health Sciences, Desh Bhagat University, Punjab, India
- Director, Faculty of Allied Health Sciences, Desh Bhagat University, Punjab, India
- Teaching Assistant, Faculty of Allied Health Sciences, Desh Bhagat University, Punjab, India
- Teaching Assistant, Faculty of Allied Health Sciences, Desh Bhagat University, Punjab, India
Abstract
Cervical cancer remains a leading cause of cancer-related morbidity and mortality among Indian women, especially in low-resource settings. While Pap smear testing has been the standard screening method, HPV DNA testing offers potential advantages in sensitivity, cost-effectiveness, and feasibility for large-scale implementation. This study compares the efficacy, cost, and acceptability of HPV screening versus Pap smears in urban and rural populations of North India. A comparative cohort study was conducted among 1,250 women (625 urban, 625 rural), aged 18 years and above, recruited through stratified random sampling across North India. Participants underwent both HPV DNA testing and Pap smears. Data on diagnostic performance, cost per detection and prevention, and acceptability were gathered through structured questionnaires and laboratory analysis. Statistical methods included descriptive analysis, chi-square tests, and logistic regression. HPV screening demonstrated higher sensitivity (93 vs. 85%) but slightly lower specificity (85 vs. 92%) compared to Pap smears. It was also more cost-effective, with lower costs per detection (₹800–1,200 vs. ₹1,500–3,000) and prevention (₹2,500–3,500 vs. ₹4,000–6,000). Urban women reported greater acceptability (HPV: 85%; Pap: 90%) than rural women (HPV: 65%; Pap: 75%), with rural hesitancy attributed to cultural barriers and privacy concerns. Screening participation was higher in urban areas (90 vs. 75%), influenced by healthcare access and educational levels. In conclusion, HPV testing is a more sensitive and cost-effective alternative to Pap smears, particularly suitable for resource-limited rural settings. Public health efforts should prioritize HPV-based screening, supported by community education and mobile outreach to reduce cervical cancer disparities.
Keywords: Cervical cancer, HPV screening, pap smear, rural health disparities, cost-effectiveness
[This article belongs to International Journal of Women’s Health Nursing And Practices ]
Eric Kwasi Elliason, Atul Khajuria, Stephen Monday, J. Samuel Kamanda. HPV Screening as an Alternative to Pap Smear in Cervical Cancer Prevention: A Comparative Study in North India. International Journal of Women’s Health Nursing And Practices. 2025; 03(02):31-37.
Eric Kwasi Elliason, Atul Khajuria, Stephen Monday, J. Samuel Kamanda. HPV Screening as an Alternative to Pap Smear in Cervical Cancer Prevention: A Comparative Study in North India. International Journal of Women’s Health Nursing And Practices. 2025; 03(02):31-37. Available from: https://journals.stmjournals.com/ijwhnp/article=2025/view=235332
References
- International Agency for Research on Cancer. (2022). India Fact Sheet: Globocan 2022. [Online].https://gco.iarc.who.int/media/globocan/factsheets/populations/356-india-fact-sheet.pdf
- Ghosh Cervical cancer incidence and mortality trends in India: A systematic review. Indian J Cancer. 2019; 56(2): 90–98. https://doi.org/10.4103/ijc.IJC_123_19
- Sankaranarayanan R, Basu P, Kaur P, et al. Current status of cervical cancer prevention in India. Indian JMed Res. 2018; 148(6): 739–745. https://doi.org/10.4103/ijmr.IJMR_1791_18
- Arbyn M, Anttila A, Jordan J, et al. European guidelines for quality assurance in cervical cancer screening. 2ndEd Luxembourg: Publications Office of the European Union; 2020. https://doi.org/10.2875/02032
- Sankaranarayanan R, Joshi SM, Vaidya HPV screening for cervical cancer prevention in low-resource settings. Glob Health Action. 2020; 13(1): 1791011. https://doi.org/10.1080/16549716.
2020.1791011 - World Medical Association. Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA. 2013; 310(20): 2191– https://doi.org/10.1001/jama.
2013.281053 - Indian Council of Medical Research (ICMR). Consensus guidelines for cervical cancer screening in India. New Delhi: ICMR; 2023.
- National Health Mission (NHM). Operational guidelines for cervical cancer screening under Ayushman Bharat. Ministry of Health and Family Welfare, Government of India. 2024.
- Sharma A, Gupta S, Dhillon Cost-effectiveness of HPV screening in low-resource settings: Evidence from North India. Indian J Med Res. 2021; 154(3): 456–465. https://doi.org/10.4103/
ijmr.IJMR_432_21 - Dutta S, Mishra G, Singh Health-seeking behavior and cervical cancer screening in rural North India. J Glob Oncol. 2022; 8: e2100298. https://doi.org/10.1200/GO.21.00298
- All India Institute of Medical Sciences (AIIMS). Annual report on cervical cancer screening outcomes. New Delhi: AIIMS; 2023.
- World Health Organization India. Cervical cancer screening implementation framework for India. India: WHO Country Office for India; 2023.
- Tata Memorial Centre. Economic burden of cervical cancer treatment in India: A hospital-based study. Mumbai: TMC; 2022.
- Ministry of Health and Family Welfare (MoHFW). National cervical cancer program operational guidelines. New Delhi: Government of India; 2023.
- Mizuno S, Nishioka Y, Yamaguchi Barriers to cervical cancer screening in low-resource settings. JWomen’s Health. 2021; 30(5): 678–685. https://doi.org/10.1089/jwh.2020.8456
- Teede H, Misso M, Costello Community-based approaches to improve cancer screening uptake. MedJ Aust. 2010; 193(9): 435–443. https://doi.org/10.5694/mja10.10145
International Journal of Women’s Health Nursing And Practices
| Volume | 03 |
| Issue | 02 |
| Received | 25/08/2025 |
| Accepted | 10/10/2025 |
| Published | 22/10/2025 |
| Publication Time | 58 Days |
Login
PlumX Metrics